Abeona Therapeutics, Inc. (ABEO)
5.40
-0.03
(-0.55%)
USD |
NASDAQ |
Sep 25, 16:00
5.405
0.00 (0.00%)
After-Hours: 19:59
Abeona Therapeutics Price to Book Value : 2.413 for Sept. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 2.413 |
| September 24, 2026 | 2.426 |
| September 23, 2026 | 2.471 |
| September 22, 2026 | 2.601 |
| September 21, 2026 | 2.534 |
| September 18, 2026 | 2.489 |
| September 17, 2026 | 2.498 |
| September 16, 2026 | 2.400 |
| September 15, 2026 | 2.444 |
| September 14, 2026 | 2.426 |
| September 11, 2026 | 2.420 |
| September 10, 2026 | 2.449 |
| September 09, 2026 | 2.587 |
| September 08, 2026 | 2.614 |
| September 04, 2026 | 2.681 |
| September 03, 2026 | 2.65 |
| September 02, 2026 | 2.659 |
| September 01, 2026 | 2.672 |
| August 31, 2026 | 2.614 |
| August 28, 2026 | 2.646 |
| August 27, 2026 | 2.699 |
| August 26, 2026 | 2.686 |
| August 25, 2026 | 2.775 |
| August 24, 2026 | 2.708 |
| August 21, 2026 | 2.722 |
| Date | Value |
|---|---|
| August 20, 2026 | 2.663 |
| August 19, 2026 | 2.739 |
| August 18, 2026 | 2.753 |
| August 17, 2026 | 2.654 |
| August 14, 2026 | 2.674 |
| August 13, 2026 | 2.835 |
| August 12, 2026 | 3.334 |
| August 11, 2026 | 3.307 |
| August 10, 2026 | 3.329 |
| August 07, 2026 | 3.235 |
| August 06, 2026 | 3.083 |
| August 05, 2026 | 3.039 |
| August 04, 2026 | 3.048 |
| August 03, 2026 | 2.856 |
| July 31, 2026 | 2.869 |
| July 30, 2026 | 2.891 |
| July 29, 2026 | 2.784 |
| July 28, 2026 | 2.690 |
| July 27, 2026 | 2.739 |
| July 24, 2026 | 2.704 |
| July 23, 2026 | 2.851 |
| July 22, 2026 | 2.869 |
| July 21, 2026 | 2.918 |
| July 20, 2026 | 2.896 |
| July 17, 2026 | 3.128 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ultragenyx Pharmaceutical, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 2.724 |
| Alnylam Pharmaceuticals, Inc. | 25.28 |
| Anika Therapeutics, Inc. | 1.986 |
| Savara, Inc. | 7.149 |
Price to Book Value Related Metrics
| PS Ratio | 11.79 |
| Price | 5.40 |
| Earnings Yield | -20.79% |
| Market Cap | 309.02M |